<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02863978</url>
  </required_header>
  <id_info>
    <org_study_id>35RC16_9714</org_study_id>
    <secondary_id>2016-A00993-48</secondary_id>
    <nct_id>NCT02863978</nct_id>
  </id_info>
  <brief_title>Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database</brief_title>
  <acronym>Digi-NewB</acronym>
  <official_title>Preliminary Study to the Conception of a Non-invasive Neonatal Monitoring System With Development of a Database</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Rennes University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Union</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>GCS Hôpitaux Universitaires Grand-Ouest</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rennes 1 University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Tampere University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Voxygen Health</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>INESC TEC Porto</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>National University of Ireland, Galway, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Synchrophi Systems Ltd</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Rennes University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Each year, 300 000 new borns are hospitalised in neonatology units in Europe. This period is
      very sensitive as newborns are exposed to a high risk of morbidity and mortality, with severe
      impact on neuro-developmental prognostic. The Rennes University Hospital was granted a
      specific funding from the European Union in the framework of the Horizon 2020 programme (Call
      PERSONALISING HEALTH AND CARE 2015-single-stage - Grant Agreement Number 689260) to develop
      the Digi-NewB project. This project aims to develop innovative non-invasive monitoring tools
      to support decision making in health. Such tools include a new generation of real time
      monitoring in neonatology using composite indices made of cardio-respiratory variables,
      movements, sounds, and clinical data. The Digi-NewB cohort aims to gather all physiological
      data relevant for the creation of the composite indices.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The database will be used to answer the following specific objectives, with priority given to
      the two first ones (sepsis and maturation) :

        1. Early diagnosis of sepsis for the following cases : Late onset sepsis of premature
           newborns, materno-fœtal sepsis, and newborn infection by chorioamnionitis

        2. Cardio-respiratory and neurobehavioral maturation (movements, sleeping cycles)

        3. Influence of environmental factors and developmental care on selected parameters

        4. Influence on care organisation of the possibility to access videos and movement analyses
           by medical teams

        5. Influence of glycemia on selected parameters

        6. Influence of neurological lesions and broncho-pulmonary dysplasia on selected parameters

        7. Indices correlation with medical images MRI (T1, T2, diffusion, Arterial Spin Labelling)
           from neonatal units and with health evaluated after 1 and 2 years with the Ages &amp; Stages
           Questionnaires (ASQ)

        8. Evaluation of the acquisition system's user-friendliness
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 8, 2016</start_date>
  <completion_date type="Anticipated">October 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of newborns in neonatology unit</measure>
    <time_frame>Four years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infection/Sepsis</measure>
    <time_frame>During the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Identification of late onset sepsis of premature newborns, materno-fœtal sepsis, and newborn infection by chorioamnionitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maturation</measure>
    <time_frame>During the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Quantification of maturation, i.e. evaluation of cardio respiratory rates and neurobehavioral maturation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Influence of environment and developmental care</measure>
    <time_frame>During the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Measure of impact of access to new variables (maturation, rates) on care organisation and system's perception by families (Likert scales)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Care givers satisfaction</measure>
    <time_frame>Each 6 months after setting up the acquisition system in the unit</time_frame>
    <description>Evaluation of carers' satisfaction with the new variables and the system's relevance in relation to their needs (&quot;use cases&quot; methods)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact on newborn's time of quiet sleep</measure>
    <time_frame>At the end of the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Quantification of the relative time of quiet sleep</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Glycemia</measure>
    <time_frame>During the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Measures of physiological impact of hypo and hyperglycemias to assess the predictive value of hyperglycemia on sepsis risk</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cerebral Electrophysiology</measure>
    <time_frame>During the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Compared evaluation of data coming from Digi-NewB cohort with available data from EEG and polysomnography (impact of cerebral damages, broncho-pulmonary dysplasia)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medium term Prognosis</measure>
    <time_frame>During the stay in neonatal unit, up to 10 weeks</time_frame>
    <description>Acquisition of magnetic resonance images (T1, T2, diffusion and cerebral perfusion arterial spin labeling) in neonatology</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prognosis evaluation</measure>
    <time_frame>At the babies 1st and 2nd birthdays</time_frame>
    <description>Assessment of the baby's neuro-development by Ages &amp; Stages Questionnaires® (ASQ) and health related events (hospitalisation, growth...)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Infant, Premature</condition>
  <arm_group>
    <arm_group_label>Digi-NewB Cohort</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multimodal signal acquisitions</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multimodal signal acquisitions</intervention_name>
    <description>Cardiac and respiratory signals are collected from the clinical monitoring routinely gathered in hospital neonatal units.
Movement quantification and baby's sounds are extracted thanks to a dedicated system which will collect images and sound with microphones and cameras.</description>
    <arm_group_label>Digi-NewB Cohort</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Newborn hospitalised in the neonatology services of participating hospitals

          -  One of the legal representatives gave its signed agreement to take part to the study

          -  New born aged of less than 6 weeks in corrected term

        Exclusion Criteria:

          -  No signed agreement from the legal representative
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Weeks</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Patrick PLADYS, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>CHU Rennes</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick PLADYS, MD, PhD</last_name>
    <phone>+336 34 19 11 30</phone>
    <email>patrick.pladys@chu-rennes.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Maude LUHERNE</last_name>
    <phone>+33 2 99 2 65994</phone>
    <email>Maude.luherne@chu-rennes.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Brest University Hospital</name>
      <address>
        <city>Brest</city>
        <state>Brittany</state>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jean-Michel ROUE, MD</last_name>
    </contact>
    <investigator>
      <last_name>Michel SIZUN, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean-Michel ROUE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Angers University Hospital</name>
      <address>
        <city>Angers</city>
        <zip>49000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Géraldine Gascoin, MD, PhD</last_name>
      <phone>+332 41 35 44 07</phone>
      <email>gegascoin@chu-angers.fr</email>
    </contact>
    <investigator>
      <last_name>Géraldine Gascoin, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Nantes University Hospital</name>
      <address>
        <city>Nantes</city>
        <zip>44000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jean-Christophe ROZE, MD, PhD</last_name>
      <phone>+332 40 08 77 02</phone>
      <email>jeanchristophe.roze@chu-nantes.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Christophe ROZE, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cyril FLAMANT, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Poitiers University Hospital</name>
      <address>
        <city>Poitiers</city>
        <zip>86000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Khaled HUSSEINI, MD</last_name>
      <phone>+335 49 44 48 98</phone>
      <email>khaled.husseini@chu-poitiers.fr</email>
    </contact>
    <investigator>
      <last_name>Khaled HUSSEINI, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rennes University Hospital</name>
      <address>
        <city>Rennes</city>
        <zip>35000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick PLADYS, MD, PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Maude LUHERNE</last_name>
    </contact_backup>
    <investigator>
      <last_name>Alain BEUCHEE, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patrick Pladys, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Tours University Hospital</name>
      <address>
        <city>Tours</city>
        <zip>37000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Géraldine FAVRAIS, MD, PhD</last_name>
      <phone>+332 47 47 47 49</phone>
      <email>g.favrais@chu-tours.fr</email>
    </contact>
    <investigator>
      <last_name>Géraldine FAVRAIS, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <link>
    <url>http://www.digi-newb.eu</url>
  </link>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 3, 2016</study_first_submitted>
  <study_first_submitted_qc>August 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 11, 2016</study_first_posted>
  <last_update_submitted>May 26, 2017</last_update_submitted>
  <last_update_submitted_qc>May 26, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 31, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Sepsis</keyword>
  <keyword>Neonates</keyword>
  <keyword>Cardio-respiratory maturation</keyword>
  <keyword>Neurobehavioral maturation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

